Moreover, neogenin has the capacity to active cell death pathway and modulate cell migration through the consumption of netrin, thus the dysregulation of neogenin has been reported in many primary tumors, such as squamous cell carcinoma, breast cancer and gloima. This evidence concerns the gene NEO1 and squamous cell carcinoma.